[PP.12.23] A RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PHASE III STUDY TO EVALUATE THE EFFICACY AND SAFETY OF THE TRIPLE COMBINATION OF AMLODIPINE/LOSARTAN/ROSUVASTATIN IN PATIENTS WITH ESSENTIAL HYPERTENSION
Keyword(s):
2016 ◽
Vol 38
(10)
◽
pp. 2159-2170
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2014 ◽
Vol 71
(3)
◽
pp. 484-492
◽
Keyword(s):
Keyword(s):
Keyword(s):
2015 ◽
Vol 33
(15_suppl)
◽
pp. 8057-8057
◽
Keyword(s):
Keyword(s):